Could a simple wearable replace the glucose test after pregnancy?

NCT ID NCT07174245

First seen Jun 26, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study looks at whether continuous glucose monitors (CGMs) worn during late pregnancy and for two weeks after birth can predict which women with gestational diabetes will have abnormal blood sugar after delivery. Currently, only a small percentage of women complete the standard glucose test after pregnancy. The goal is to find a more convenient way to identify those who need follow-up care. The study will enroll 40 women and compare CGM data to the standard oral glucose tolerance test.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
continuous glucose monitor (CGM)
What this could lead to
If successful, this could lead to a simpler, more accessible way to screen for postpartum blood sugar problems in women with gestational diabetes.
What could go wrong
This is a small, early-stage study (40 participants) focused on observation, not treatment. The findings may not apply to all women or change current screening guidelines.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Icahn School of Medicine at Mount Sinai

    RECRUITING

    New York, New York, 10029, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.